Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's disease

Effective prevention and treatment of Alzheimer's disease depends on the identification of accurate, rapid and non-invasive biomarkers. Peripheral blood and biological fluids such as plasma, serum, and cerebrospinal fluid are valuable samples for the detection of biomarkers because they cause l...

Full description

Bibliographic Details
Main Authors: Taiebeh Kafshdooz, Safar Farajnia, Rasoul Sharifi, Safa Najmi
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S235291482300045X
_version_ 1827965415153729536
author Taiebeh Kafshdooz
Safar Farajnia
Rasoul Sharifi
Safa Najmi
author_facet Taiebeh Kafshdooz
Safar Farajnia
Rasoul Sharifi
Safa Najmi
author_sort Taiebeh Kafshdooz
collection DOAJ
description Effective prevention and treatment of Alzheimer's disease depends on the identification of accurate, rapid and non-invasive biomarkers. Peripheral blood and biological fluids such as plasma, serum, and cerebrospinal fluid are valuable samples for the detection of biomarkers because they cause little discomfort to the patient and facilitate the diagnosis of the disease in the early stages. Small non-coding RNAs known as microRNA (miRNA) play a vital role in regulating various signaling pathways and are involved in various diseases. More than 70% of experimentally confirmed miRNAs are expressed in the brain which can be used as potential diagnostic biomarkers of AD. In silico pathway analysis by DIANA-Mir Path confirmed that miR-let-7g is involved in chronic myeloid leukemia, cell cycle, melanoma and pancreatic cancer pathways. This study aimed to evaluate the hsa-let7g-5p miRNA as a possible blood biomarker for the early detection of AD.Samples of blood were taken from 30 AD patients and 30 healthy people. RNA total was isolated from serum samples and converted to cDNA and the expression level of Let7 miRNAs was measured by the real-time PCR method.The results of the study showed that the expression of hsa-let7g-5p was significantly decreased in patients with AD compared to the normal cases. The AROC for hsa-let-7g-5p transcript levels was 0.4032 compared to the 0.7869 from the normal control group (P = 0.035; 95% CI, 0.27–0.90). These findings suggest that hsa-let7g-5p miRNAs may be used as a potential biomarker for AD diagnosis.
first_indexed 2024-04-09T17:32:40Z
format Article
id doaj.art-99ca2bf8fb394f1a8f6beee19aeb5bc5
institution Directory Open Access Journal
issn 2352-9148
language English
last_indexed 2024-04-09T17:32:40Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Informatics in Medicine Unlocked
spelling doaj.art-99ca2bf8fb394f1a8f6beee19aeb5bc52023-04-18T04:08:53ZengElsevierInformatics in Medicine Unlocked2352-91482023-01-0138101203Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's diseaseTaiebeh Kafshdooz0Safar Farajnia1Rasoul Sharifi2Safa Najmi3Department of Biology, Faculty of Basic Sciences, Islamic Azad University, Ahar, IranDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Corresponding author. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.Department of Biology, Faculty of Basic Sciences, Islamic Azad University, Ahar, IranBiotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, IranEffective prevention and treatment of Alzheimer's disease depends on the identification of accurate, rapid and non-invasive biomarkers. Peripheral blood and biological fluids such as plasma, serum, and cerebrospinal fluid are valuable samples for the detection of biomarkers because they cause little discomfort to the patient and facilitate the diagnosis of the disease in the early stages. Small non-coding RNAs known as microRNA (miRNA) play a vital role in regulating various signaling pathways and are involved in various diseases. More than 70% of experimentally confirmed miRNAs are expressed in the brain which can be used as potential diagnostic biomarkers of AD. In silico pathway analysis by DIANA-Mir Path confirmed that miR-let-7g is involved in chronic myeloid leukemia, cell cycle, melanoma and pancreatic cancer pathways. This study aimed to evaluate the hsa-let7g-5p miRNA as a possible blood biomarker for the early detection of AD.Samples of blood were taken from 30 AD patients and 30 healthy people. RNA total was isolated from serum samples and converted to cDNA and the expression level of Let7 miRNAs was measured by the real-time PCR method.The results of the study showed that the expression of hsa-let7g-5p was significantly decreased in patients with AD compared to the normal cases. The AROC for hsa-let-7g-5p transcript levels was 0.4032 compared to the 0.7869 from the normal control group (P = 0.035; 95% CI, 0.27–0.90). These findings suggest that hsa-let7g-5p miRNAs may be used as a potential biomarker for AD diagnosis.http://www.sciencedirect.com/science/article/pii/S235291482300045XAlzheimer's disease (AD)MicroRNA (miRNA)BiomarkerLet-7
spellingShingle Taiebeh Kafshdooz
Safar Farajnia
Rasoul Sharifi
Safa Najmi
Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's disease
Informatics in Medicine Unlocked
Alzheimer's disease (AD)
MicroRNA (miRNA)
Biomarker
Let-7
title Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's disease
title_full Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's disease
title_fullStr Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's disease
title_full_unstemmed Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's disease
title_short Hsa-let-7g-5p, a circulating microRNA, as a biomarker for Alzheimer's disease
title_sort hsa let 7g 5p a circulating microrna as a biomarker for alzheimer s disease
topic Alzheimer's disease (AD)
MicroRNA (miRNA)
Biomarker
Let-7
url http://www.sciencedirect.com/science/article/pii/S235291482300045X
work_keys_str_mv AT taiebehkafshdooz hsalet7g5pacirculatingmicrornaasabiomarkerforalzheimersdisease
AT safarfarajnia hsalet7g5pacirculatingmicrornaasabiomarkerforalzheimersdisease
AT rasoulsharifi hsalet7g5pacirculatingmicrornaasabiomarkerforalzheimersdisease
AT safanajmi hsalet7g5pacirculatingmicrornaasabiomarkerforalzheimersdisease